UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000015363
Receipt No. R000017879
Official scientific title of the study ILM Blue assisted membrane peeling in vitrectomy
Date of disclosure of the study information 2014/11/15
Last modified on 2016/04/07 (Ver. 8)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study ILM Blue assisted membrane peeling in vitrectomy
Title of the study (Brief title) ILM Blue assisted membrane peeling in vitrectomy
Region
Japan

Condition
Condition macular hole, epiretinal membrane, macular edema, retinoschisis, retinal detachment
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 to evaluate the safety and the efficacy of ILM Blue assisted membrane peeling
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes the frequency and the content of adverse effects
Key secondary outcomes visual acuity change in 1, 3, and 12 months after surgery
visual field change in 3 and 12 months after surgery
the quality of ILM staining
the rate of complete ILM peeling
the rate of macular hole

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 ILM staining with ILM Blue
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria the diagnosis of macular hole, macular edema, epiretinal membrane, retinoschisis, or retinal detachment by slit lamp microscopy, fundusscopy, and optical coherence tomography.
And required surgical treatment.
Key exclusion criteria 1.2 or better of visual acuity
the patients with glaucoma
younger than 20 years old, nursing women, pregnancy

Target sample size 150

Research contact person
Name of lead principal investigator Suzuma Kiyoshi
Organization Kyoto University Graduate School of Medicine
Division name Department of Ophthalmology and Visual Science
Address 54ShogoinKawaharacho, Sakyo, Kyoto, Japan
TEL 075-751-3248
Email suzuma@kuhp.kyoto-u.ac.jp

Public contact
Name of contact person Ai Higashiyama
Organization Kyoto University Graduate School of Medicine
Division name Department of Ophthalmology and Visual Science
Address 54ShogoinKawaharacho, Sakyo, Kyoto, Japan
TEL 075-751-3250
Homepage URL
Email ahigashi@kuhp.kyoto-u.ac.jp

Sponsor
Institute Kyoto University Graduate School of Medicine, Department of Ophthalmology and Visual Science
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization donation money for research
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 11 Month 15 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2014 Year 10 Month 07 Day
Anticipated trial start date
2015 Year 01 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 10 Month 07 Day
Last modified on
2016 Year 04 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-bin/icdr_e/ctr_view.cgi?recptno=R000017879